Efficacy and Safety of Combined Nanofat Injection With Either Platelet Rich Fibrin or Microneedling Versus Nanofat Injection Alone in the Treatment of Facial Atrophic Post Acne Scars

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-45
SponsorAssiut University

About this trial

To compare the efficacy and safety of combined nanofat injection with either platelet rich fibrin or microneedling versus nanofat injection alone in the treatment of facial atrophic post acne scars.

Eligibility criteria

Qualifiers

Patients older than 18 years of both sexes with moderate to severe atrophic facial acne scars on both cheeks

Disqualifiers

1. Patients' age <18 or >45 years 2. Pregnant and lactating women 3. active inflammatory acne or active infection in the treatment area. 4. treatment of the targeted study sites within 2 months 5. history of chronic diseases (autoimmune diseases, bleeding disorders, taking anticoagulant therapy or aspirin) 6. history of hypertrophic scars or keloid formation tendency. 7. patients with unrealistic expectations.

Trial design

Treatments tested in this trial

  • nanofat injecion
  • Platelet rich fibrin
  • Microneedling

Treatment groups

42 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators